Navigation Links
American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications
Date:2/18/2009

Reviewer Finder to Speed up the Peer Review Process!

COLUMBIA, S.C., Feb. 18 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that the American Association for Cancer Research (AACR) has licensed the Collexis' Reviewer Finder and Journal Dashboard applications for the 6 AACR cancer research journals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )

"The Collexis Review Finder application will certainly enhance and improve our peer review process as we continuously strive to target the most appropriate reviewers", stated Diane Scott-Lichter, Publisher of AACR. "The Journal Dashboard will provide us with key insights concerning the positioning of our journals in the area of cancer research."

"Having the AACR to sign up for our Reviewer Finder application is quite gratifying for us since AACR is the first society to adopt the Reviewer Finder for the publishing process - until today most of the Reviewer Finder customers were other funding organizations like the NHLBI at the NIH and the Wellcome Trust," said Christian Herzog, MD, Managing Director of the Collexis STM Business Unit. "As the AACR begins to use the Journal Dashboards as journal portfolio analysis tools, we are very confident that it will help them to sharpen the profile of their journals."

The Collexis Reviewer Finder helps publishing organizations in two very important ways: first it assists in reducing the time to identify the most qualified reviewers from hours to virtually minutes by automatically suggesting best matching reviewers for a manuscript, secondly it enhances security by identifying potential conflicts of reviewers based on co-authorship and institutional affiliation. The Collexis Reviewer Finder will be integrated into the publishing workflow solution that AACR is using.

The Collexis Journal Dashboard is providing the customer a complex view to analyze the portfolio of a journal, to compare it on a granular basis to others, to understand author patterns and emerging trends - providing insights for strategic decisions on positioning and further development.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis now offers the world's first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with the company's collaboration with the American Association for Cancer Research. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-K for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.


'/>"/>
SOURCE Collexis Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
2. BioIQ Supports American Heart Month to Raise Awareness About Heart Disease, the #1 Killer of Women
3. New General Manager, Transition to New Raleigh Offices Highlight Datatrials Expansion of North American Operations
4. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
5. American Oriental Bioengineering to Participate in the 2009 UBS Greater China Conference
6. American Oriental Bioengineering Comments on Recent Property Purchase
7. Tips from the journals of the American Society for Microbiology
8. Elsevier Introduces The American Journal of Medicine Blog
9. The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database
10. Transgenomic Receives Accreditation From College of American Pathologists
11. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , ... April 27, 2016 , ... The Pittcon Organizing ... 2019. Chuck has been a volunteer member of Committee since 1987. Since then, ... board of directors and treasurer and was chairman for both the program and exposition ...
(Date:4/27/2016)... RESEARCH TRIANGLE PARK, N.C. , April 27, ... ) announced today that Martine Rothblatt , Ph.D., ... provide an overview and update on the company,s business ... Care Conference. The presentation will take place ... Time, and can be accessed via a live webcast ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding ... detection. , PathSensors deploys the CANARY® test platform for the detection of ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group and the ... as other research and development initiatives for potential stem cell protocol management for 2016 ... Cells Group executives began meeting to establish a working agenda and foster initiatives to ...
Breaking Biology Technology:
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
Breaking Biology News(10 mins):